相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life
Michael Maes et al.
CNS SPECTRUMS (2022)
Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia
Abbas F. Almulla et al.
CNS SPECTRUMS (2021)
Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates
Rana Fadhil Mousa et al.
METABOLIC BRAIN DISEASE (2021)
High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments
Arafat Hussein Al-Dujaili et al.
SCHIZOPHRENIA BULLETIN (2021)
Diagnostic Task Specific Activations in Functional MRI and Aberrant Connectivity of Insula with Middle Frontal Gyrus Can Inform the Differential Diagnosis of Psychosis
Drozdstoy Stoyanov et al.
DIAGNOSTICS (2021)
How to construct neuroscience-informed psychiatric classification? Towards nomothetic networks psychiatry
Drozdstoy Stoyanov et al.
WORLD JOURNAL OF PSYCHIATRY (2021)
Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia
Michael Maes et al.
MOLECULAR NEUROBIOLOGY (2021)
Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia
Hussein K. Al-Hakeim et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways
Abbas F. Almulla et al.
SCHIZOPHRENIA RESEARCH (2020)
Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach
Michael Maes et al.
MOLECULAR NEUROBIOLOGY (2020)
The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major Depression
Leszek Rudzki et al.
MOLECULAR NEUROBIOLOGY (2020)
Environmental, Neuro-immune, and Neuro-oxidative Stress Interactions in Chronic Fatigue Syndrome
Geir Bjorklund et al.
MOLECULAR NEUROBIOLOGY (2020)
How to Construct a Bottom-Up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia
Michael Maes et al.
BRAIN SCIENCES (2020)
Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia
Michael Maes et al.
MOLECULAR NEUROBIOLOGY (2019)
Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia
Buranee Kanchanatawan et al.
METABOLIC BRAIN DISEASE (2019)
Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway
Buranee Kanchanatawan et al.
METABOLIC BRAIN DISEASE (2017)
HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease
Barry W. Festoff et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes (Publication with Expression of Concern. See vol. 3, 2018)
Huan Yang et al.
JCI INSIGHT (2016)
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics
Gerwyn Morris et al.
BMC MEDICINE (2013)
Executive Functioning in Schizophrenia
Gricel Orellana et al.
Frontiers in Psychiatry (2013)
Schizophrenia in Thailand: prevalence and burden of disease
Pudtan Phanthunane et al.
POPULATION HEALTH METRICS (2010)
Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): Indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability
Michael Maes et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal
MT Lotze et al.
NATURE REVIEWS IMMUNOLOGY (2005)
A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale)
O Zachrisson et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2002)
Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16
M Maes et al.
PSYCHIATRY RESEARCH (2001)
分享论文
